Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions
This study has been completed.
Sponsor:
Ranbaxy Laboratories Limited
Information provided by:
Ranbaxy Inc.
ClinicalTrials.gov Identifier:
NCT00778778
First received: October 22, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2005 |
| Primary Completion Date: | June 2005 (Final data collection date for primary outcome measure) |